Jeremy C. Durack, MD, MS

About Me

I am an interventional radiologist (IR) with expertise in a wide range of minimally invasive image-guided procedures. My particular clinical interests include the treatment of genitourinary cancers – including kidney cancer, bladder cancer, and prostate cancer – and blood clots (venous thrombolysis and stenting). I currently lead the Ablation of Renal Masses Outcome Registry (ARMOR), which is an international registry evaluating patient outcomes after kidney cancer ablation.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.

I believe the best possible care for patients and caregivers results from understanding and partnership.  These partnerships often begin in the IR clinic before any procedure is performed, where I meet with patients and families to discuss options for diagnosis and treatment. After a procedure, we meet to review results and imaging studies, and answer questions. My goal is to ensure that patients are informed and involved at every step.

Interventional radiology is an expanding specialty driven by continual innovation. I am proud to serve on the leadership committee of the Society of Interventional Radiology Foundation, which supports IR education and research. In addition to the treatment of kidney cancer, my own research interests include clinical decision support systems to enhance the quality of care, patient registries, technologies to improve the value of biopsies, and patient reported outcomes studies. Based on my experience and interests in these areas, I also serve as Vice-Chair for Information Technology, Safety, Quality and Performance Improvement for the Department of Radiology at Memorial Sloan Kettering.

  • Clinical Expertise: Ablation; Thrombolysis (Treatment of Blood Clots); Vascular Interventions; Genitourinary Malignancies (Kidney Cancer, Bladder Cancer; Prostate Cancer)
  • Awards and Honors: National Institute of Biomedical Imaging and Bioengineering T32 Research Training Award; Roentgen Research Award, Radiological Society of North America; Prostate Cancer Foundation Young Investigator Award (2014); Fellow, Society of Interventional Radiology (FSIR); Castle Connolly Top Doctor (2016-2018)
  • Languages Spoken: English
  • Education: MD, Stanford University School of Medicine; MS, Biological and Medical Informatics, University of California, San Francisco (UCSF) School of Medicine
  • Residencies: UCSF School of Medicine
  • Fellowships: UCSF School of Medicine; Stanford University Medical Center
  • Board Certifications: Vascular and Interventional Radiology; Diagnostic Radiology; Clinical Informatics

My Research

Microscope iconAn icon showing a microscope. View my lab Arrow rightAn icon showing an arrow pointing to the right.

See Jeremy C. Durack’s laboratory
research at Memorial Sloan Kettering.


Visit PubMed for a full listing of Jeremy C. Durack’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.